August 15, 2026 04:02 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Ajit Doval breaks silence on Operation Sindoor in Discovery’s explosive new docuseries | Rahul Gandhi's 'mock hug' taunt sparks row; Centre stresses 'mutual respect' with Italy | Delhi on high alert: Bomb threat to High Court, airport and multiple locations ahead of I-Day | ‘Who are they to interfere?’: CJI Surya Kant slams Bar Council of India over NALSAR students’ enrolment row | 'Shows how low Congress has sunk': BJP slams Rahul Gandhi over Modi foreign policy jibe | From guns to glamour: Former women Maoists walk the ramp in Chhattisgarh | Netaji row: Suvendu Adhikari govt strips BJP MP Anant Maharaj of state honour | Sukhbir Badal attacked by Nihang Sikh with kirpan at Maharashtra gurdwara; assailant detained | ‘If you cannot do it, we will pass an order’: Supreme Court’s final warning to Centre on food labels | ‘Time to move on’: Bombay HC sends strong message in Vijay Mallya-bank dispute

Genpact appoints Hanspeter Spek as Director

| | Apr 04, 2014, at 12:08 am
New York, Apr 3 (IBNS): Business process management company Genpact Limited on Thursday announced Hanspeter Spek as a member of its Board of Directors.
“We are honored to have Hanspeter join the Genpact Board. With his extensive global experience, he will bring significant value to Genpact and its Board,” said Robert Scott, Chairman of the Board, Genpact. 
 
Spek, who also currently serves as Chairman of the Board of Sanofi Germany, spent his career in the pharmaceutical industry where he most recently served as president of Global Operations at Sanofi S.A. before retiring in June 2013. 
 
Beginning his career at Pfizer, where he spent more than 10 years in increasingly responsible product and marketing management roles,Spek then joined Sanofi in 1985. 
 
His tenure there spanned a number of senior management roles including senior vice president of Europe following the merger with Synthélabo in 1999, director of Worldwide Operations of Sanofi-Synthélabo, and executive vice president of Global Pharmaceutical Operations for Sanofi-Aventis before he was promoted to president of Global Operations in 2009. 
 
A native of Germany, he currently resides in Paris.
 
“Genpact is thrilled to add another outstanding business leader to our Board. Hanspeter, who has had such a long and distinguished career in the pharmaceutical and life sciences industry, will bring great insights in one of our core focus industries,” said NV ‘Tiger’ Tyagarajan, president and CEO, Genpact. 
 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.